Lipoxin b is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with Lipoxin b
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Inflammation | D007249 | 119 associated lipids |
| Leukemia, Erythroblastic, Acute | D004915 | 41 associated lipids |
| Asthma | D001249 | 52 associated lipids |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | D015464 | 17 associated lipids |
| Nasal Polyps | D009298 | 26 associated lipids |
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Karra L et al. | Lipoxin Bâ‚„ promotes the resolution of allergic inflammation in the upper and lower airways of mice. | 2015 | Mucosal Immunol | pmid:25465102 |
| O'Sullivan TP et al. | Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities. | 2007 | J. Med. Chem. | pmid:17960922 |
| Parkinson JF | Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation. | 2006 | Inflamm Allergy Drug Targets | pmid:16613568 |
| Serhan CN | Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. | 2005 Sep-Oct | Prostaglandins Leukot. Essent. Fatty Acids | pmid:16005201 |
| Ariel A et al. | Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. | 2003 | J. Immunol. | pmid:12794159 |
| Goh J et al. | Lipoxins: pro-resolution lipid mediators in intestinal inflammation. | 2003 | Gastroenterology | pmid:12671901 |
| Bonnans C et al. | Lipoxins are potential endogenous antiinflammatory mediators in asthma. | 2002 | Am. J. Respir. Crit. Care Med. | pmid:12045128 |
| Stenson C et al. | Biphasic regulation of leukocyte trafficking by lipoxins. | 2002 | Adv. Exp. Med. Biol. | pmid:12664638 |
| Serhan CN | Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side. | 2001 | Arch. Immunol. Ther. Exp. (Warsz.) | pmid:11478391 |
| McMahon B et al. | Lipoxins: revelations on resolution. | 2001 | Trends Pharmacol. Sci. | pmid:11478982 |
| Tornhamre S et al. | 15-Lipoxygenation of leukotriene A(4). Studies Of 12- and 15-lipoxygenase efficiency to catalyze lipoxin formation. | 2000 | Biochim. Biophys. Acta | pmid:10760478 |
| Desplat V et al. | Effects of lipoxygenase metabolites of arachidonic acid on the growth of human blood CD34(+) progenitors. | 2000 | Blood Cells Mol. Dis. | pmid:11112380 |
| Serhan CN et al. | Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity. | 2000 | Ernst Schering Res. Found. Workshop | pmid:10943332 |
| Sanak M et al. | Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. | 2000 | Eur. Respir. J. | pmid:10933083 |
| Denizot Y et al. | Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells. | 2000 | Cytokine | pmid:10857767 |
| Kikuta Y et al. | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 2000 | Arch. Biochem. Biophys. | pmid:11185557 |
| Desplat V et al. | Incorporation and effect of arachidonic acid on the growth of human myeloma cell lines. | 1999 | Mediators Inflamm. | pmid:10704149 |
| Serhan CN et al. | Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogs inhibit neutrophil-mediated changes in vascular permeability. | 1999 | Adv. Exp. Med. Biol. | pmid:10667343 |
| Takano T et al. | Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. | 1998 | J. Clin. Invest. | pmid:9466977 |
| Maddox JF et al. | Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity. | 1998 | FASEB J. | pmid:9535221 |